These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6531439)

  • 1. Effects of chronic phenelzine in the rat: altered tissue weights and metabolism of 14C-phenelzine.
    Danielson TJ; Torok-Both G; Coutts RT
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):677-82. PubMed ID: 6531439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of beta-phenylethylamine from the antidepressant, beta-phenylethylhydrazine.
    Dyck LE; Durden DA; Boulton AA
    Biochem Pharmacol; 1985 Jun; 34(11):1925-9. PubMed ID: 4004908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic N-methylation of phenelzine catalyzed by methyltransferases from adrenal and other tissues.
    Yu PH; Davis BA; Durden DA
    Drug Metab Dispos; 1991; 19(4):830-4. PubMed ID: 1680662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and specificity of phenelzine and benserazide as inhibitors of benzylamine oxidase and monoamine oxidase.
    Andree TH; Clarke DE
    Biochem Pharmacol; 1982 Mar; 31(5):825-30. PubMed ID: 7082351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine.
    Baker G; Matveychuk D; MacKenzie EM; Holt A; Wang Y; Kar S
    Chem Biol Interact; 2019 May; 304():139-147. PubMed ID: 30857888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent studies on the MAO inhibitor phenelzine and its possible metabolites.
    McKenna KF; Baker GB; Coutts RT; Rauw G; Mozayani A; Danielson TJ
    J Neural Transm Suppl; 1990; 32():113-8. PubMed ID: 1982447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain.
    Ask AL; Fagervall I; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):79-87. PubMed ID: 6646243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deuterium isotope effect of phenelzine on the inhibition of rat liver mitochondrial monoamine oxidase activity.
    Yu PH; Tipton KF
    Biochem Pharmacol; 1989 Dec; 38(23):4245-51. PubMed ID: 2597196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.
    Griebel G; Curet O; Perrault G; Sanger DJ
    Neuropharmacology; 1998 Jul; 37(7):927-35. PubMed ID: 9776388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine.
    Johnstone EC
    Psychopharmacologia; 1976 Apr; 46(3):289-94. PubMed ID: 951464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of aromatic L-amino acid decarboxylase and tyrosine aminotransferase by the monoamine oxidase inhibitor phenelzine.
    Dyck LE; Dewar KM
    J Neurochem; 1986 Jun; 46(6):1899-903. PubMed ID: 2871132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue levels and some pharmacological properties of an acetylated metabolite of phenelzine in the rat.
    Coutts RT; Mozayani A; Danielson TJ; Baker GB
    J Pharm Sci; 1991 Aug; 80(8):765-7. PubMed ID: 1791538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free radical pathways in the in vitro hepatic metabolism of phenelzine.
    Ortiz de Montellano PR; Watanabe MD
    Mol Pharmacol; 1987 Feb; 31(2):213-9. PubMed ID: 3807896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of rat brain tyrosine levels by phenelzine is mediated by its active metabolite β-phenylethylidenehydrazine.
    Matveychuk D; Nunes E; Ullah N; Aldawsari FS; Velázquez-Martínez CA; Baker GB
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():67-73. PubMed ID: 24607770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidase-inhibiting properties of SR 95191, a new pyridazine derivative, in the rat: evidence for selective and reversible inhibition of monoamine oxidase type A in vivo but not in vitro.
    Kan JP; Steinberg R; Leclercq J; Worms P; Biziere K
    J Neurochem; 1988 Apr; 50(4):1137-44. PubMed ID: 3346672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic acetylation of phenelzine in rats.
    Mozayani A; Coutts RT; Danielson TJ; Baker GB
    Res Commun Chem Pathol Pharmacol; 1988 Dec; 62(3):397-406. PubMed ID: 3222522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic deuterated and non-deuterated phenelzine on rat brain monoamines and monoamine oxidase.
    Dyck LE; Juorio AV; Durden DA; Boulton AA
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Mar; 337(3):279-83. PubMed ID: 3393230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--I. Studies in vitro.
    Clineschmidt BV; Horita A
    Biochem Pharmacol; 1969 May; 18(5):1011-20. PubMed ID: 4389278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.